Key Points
- TD SYNNEX is scheduled to report earnings before the market opens Thursday, with investors watching whether the IT distribution giant can extend the strong revenue growth reported in its previous quarter.
- The company generated $19.57 billion in revenue last quarter, up 31% year over year, while also exceeding analysts’ EPS expectations and delivering a strong outlook relative to estimates.
- Analysts expect revenue growth of 21.4% this quarter, compared with 6.6% growth in the same quarter last year, while SNX shares have gained 18.2% over the past month.
TD SYNNEX is approaching its latest earnings report with investors focused on whether the company can maintain the acceleration seen in its previous quarter. The IT distribution company is scheduled to release results before the opening bell Thursday, making it one of the first major companies in the technology hardware and electronics distribution segment to report this earnings season.
The setup follows an unusually strong previous quarter. TD SYNNEX generated $19.57 billion in revenue, representing 31% year-over-year growth. The company also exceeded analysts’ earnings-per-share expectations and delivered an impressive performance relative to expectations for the following quarter.
Revenue Growth Remains the Central Focus
The latest market expectations point to another period of significant expansion. Analysts are forecasting revenue growth of 21.4% year over year for the current quarter, substantially higher than the 6.6% increase recorded during the same quarter last year.
The longer-term revenue trend shown in the company’s results also provides important context. Quarterly revenue moved from approximately $5 billion to more than $15 billion in earlier periods and has continued climbing, reaching roughly $19 billion in the latest quarters. The latest chart indicates that TD SYNNEX has maintained a broad upward trajectory in revenue despite fluctuations between individual quarters.
Analysts Are Holding Their Estimates
Expectations have remained relatively stable heading into the announcement. Analysts covering TD SYNNEX have generally reaffirmed their forecasts over the past 30 days, suggesting that there has not been a significant shift in the market’s view of the company’s near-term operating performance.
That stability is notable because TD SYNNEX has historically been a company that rarely misses Wall Street’s revenue estimates. As a result, investors may place particular emphasis on whether the company can once again deliver revenue above expectations while maintaining the earnings momentum established in the previous quarter.
SNX Is Outperforming Its Broader Peer Group
TD SYNNEX enters the report with considerably stronger recent share-price momentum than the broader technology hardware and electronics segment. The company’s shares have gained 18.2% over the past month, while stocks across the segment have declined by an average of 1.1% during the same period.
That performance raises the importance of the earnings report. A strong result could provide further support for the recent rally, while a weaker-than-expected outlook could test the premium investors have placed on the shares ahead of the announcement.
What Investors May Watch Next
The main indicators will be revenue growth, earnings performance and management’s outlook for the coming quarter. Because TD SYNNEX is among the first companies in its peer group to report, its results could also provide an early indication of demand conditions across technology hardware and electronics distribution. Investors may compare actual revenue with the expected 21.4% year-over-year increase while assessing whether the company’s recent acceleration can continue.
Comparison, examination, and analysis between investment houses
Leave your details, and an expert from our team will get back to you as soon as possible
* This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.
To read more about the full disclaimer, click here- sagi habasov
- •
- 5 Min Read
- •
- ago 21 hours
SKN | Can Aytu BioPharma’s Q4 Results Clarify Its Path Beyond Continued Losses?
Aytu BioPharma is set to release its fiscal fourth-quarter 2026 results after the U.S. market closes on September 22. The
- ago 21 hours
- •
- 5 Min Read
Aytu BioPharma is set to release its fiscal fourth-quarter 2026 results after the U.S. market closes on September 22. The
- Ronny Mor
- •
- 7 Min Read
- •
- ago 22 hours
SKN | Could MillerKnoll’s Q1 Earnings Reveal Whether Margin Pressure Is Temporary?
MillerKnoll is heading into its fiscal first-quarter 2027 earnings release with investors closely watching whether demand and profitability can withstand
- ago 22 hours
- •
- 7 Min Read
MillerKnoll is heading into its fiscal first-quarter 2027 earnings release with investors closely watching whether demand and profitability can withstand
- omer bar
- •
- 6 Min Read
- •
- ago 22 hours
SKN | Could AutoZone’s Earnings Report Help the Stock Recover From a 52-Week Low?
AutoZone shares are heading into the company's fiscal fourth-quarter results under pressure after the stock reached a new 52-week low
- ago 22 hours
- •
- 6 Min Read
AutoZone shares are heading into the company's fiscal fourth-quarter results under pressure after the stock reached a new 52-week low
- sagi habasov
- •
- 7 Min Read
- •
- ago 1 day
SKN | Could Medicare GLP-1 Coverage Accelerate Eli Lilly’s Obesity Drug Growth?
Medicare Coverage Expands the GLP-1 Market Eli Lilly is seeing significant early demand from Medicare beneficiaries following the launch of
- ago 1 day
- •
- 7 Min Read
Medicare Coverage Expands the GLP-1 Market Eli Lilly is seeing significant early demand from Medicare beneficiaries following the launch of